10 results
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
SideEffects #Table #DecisionAid ... #Orals #DM2 #Diabetes ... #Endocrinology ... #Pharmacology #Management
Diabetes Combination Tablets - Estimated A1c Lowering 
Metformin + DPP4 
• Janumet (metformin + sitagliptin) 
•
Diabetes Combination ... /ambcarerx #Diabetes ... Tablets #Oral #DM2 ... #Pharmacology # ... Pills #Endocrinology
Diabetes Type 2 Medication Management and Titration Algorithm
- First line therapy is metformin and comprehensive lifestyle
Diabetes Type 2 ... Medication Management ... line therapy is metformin ... #DM2 #Type2 #Medication ... #endocrinology
Diabetes Medication Choice
-Diabetes Medication Choice decision aid cards provide information on medications commonly used to treat
- To date only metformin ... images/2507 #Management ... #DM2 #PatientInfo ... #DecisionAid #Medications ... Reduction #Costs #Pharmacology
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... modifications Metformin ... table #comparison #management ... #endocrinology ... #dm2
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... EricsMedicalLectures/ #Metformin ... #Pharmacology # ... Summary #DM2 #diabetes ... #endocrinology
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
Hypoglycemics in Diabetes ... Management 1 ... Sensitivity - Metformin ... #Management #pharmacology ... #DM2 #DMII #Classification
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
class of anti-diabetic ... combo product with metformin ... SGLT2 #Inhibitors #Pharmacology ... #Medications #DM2 ... #Diabetes #Endocrinology
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
Management of Diabetes ... FDA recommends, metformin ... ml/min per 1.73 m2 ... with metformin. ... evidence-based pharmacologic
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Renal #Dosing #Pharmacology ... #Management #Diabetes ... #DM2 #Endocrinology